Maravai LifeSciences Holdings Inc (MRVI)
7.845
+0.08
(+0.97%)
USD |
NASDAQ |
Nov 05, 14:49
Maravai LifeSciences Holdings Profit Margin (Quarterly): -10.33% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -10.33% |
| March 31, 2024 | -18.82% |
| December 31, 2023 | -142.9% |
| September 30, 2023 | -9.66% |
| June 30, 2023 | -9.49% |
| March 31, 2023 | -0.08% |
| December 31, 2022 | 18.38% |
| September 30, 2022 | 23.25% |
| June 30, 2022 | 29.35% |
| March 31, 2022 | 27.37% |
| Date | Value |
|---|---|
| December 31, 2021 | 24.44% |
| September 30, 2021 | 26.35% |
| June 30, 2021 | 22.57% |
| March 31, 2021 | 15.59% |
| December 31, 2020 | 13.35% |
| September 30, 2020 | 44.33% |
| June 30, 2020 | 0.44% |
| March 31, 2020 | 45.88% |
| December 31, 2019 | -26.16% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-142.9%
Minimum
Dec 2023
45.88%
Maximum
Mar 2020
3.89%
Average
15.59%
Median
Mar 2021
Profit Margin (Quarterly) Benchmarks
| Repligen Corp | 2.16% |
| Evoke Pharma Inc | -49.67% |
| Personalis Inc | -56.70% |
| Tempus AI Inc | -332.7% |
| Codexis Inc | -160.8% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -15.98% |
| Return on Assets | -7.41% |
| Return on Invested Capital | -9.78% |
| Gross Profit Margin (Quarterly) | 47.86% |
| Operating Margin (Quarterly) | -14.59% |
| Return on Net Operating Assets | -9.36% |